Levels and molecular size distribution of serum laminin in adult type I diabetic patients with and without microangiopathy

Metabolism: Clinical and Experimental

Volumn 47, Issue 1, 1998, Pages 63-69

  Werle, Egon ^b   Diehl, Edmund ^b   Hasslacher, Christoph ^a  

^a StJosefs Krankenhaus Heidelberg   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LAMININ;

ADULT; AGED; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0031908828     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90194-9     Document Type: Article

References (40)

1. Timpl R, Wiedemann H, van Delden V, et al: A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochcm 120:203-211, 1981
2. Falk RJ, Schcinman JI, Mauer SM, et al: Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32:34-39, 1983 (suppl 2)
3. Sternberg M, Cohen-Forterre L, Peyroux J: Connective tissue in diabetes mellitus: Biochemical alterations of the intercellular matrix with special reference to proteoglycans, collagens and basement membranes. Diabete Metab 11:27-50, 1985
4. Shimomura H, Spiro RG: Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36:374-381, 1987
5. Schleicher E, Nerlich A, Gerbitz KD: Pathobiochemical aspects of diabetic nephropathy. Klin Wochenschr 66:873-882, 1988
6. Bosman FT, Cleutjens J, Beek C, et al: Basement membrane heterogeneity. Histochem J 21:629-633, 1989
7. Timpl R: Structure and biological activity of basement membrane proteins. Eur J Biochem 180:487-502, 1989
8. Hunter I, Schulthess T, Engel I: Laminin chain assembly by triple and double stranded coiled-coil structures. J Biol Chem 267:6006-6011, 1992
9. Aumailley M: Structure and supramolecular organization of basement membranes. Kidney Int 47:4-7, 1995
10. King GL, Brownlee M: The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25:255-270, 1996
11. Hasslacher C, Reichenbacher R, Gechter F, et al: Glomerular basement membrane synthesis and serum concentration of type IV collagen in streptozotocin-diabetic rats. Diabetologia 26:150-154, 1984
12. Karttunen T, Risteli J, Autio-Harmainen H, et al: Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 30:586-591, 1986
13. Ikeda S, Makino H, Haramoto T, et al: Changes in glomerular extracellular matrices components in diabetic ncphropathy. J Diabetes Complications 5:186-188, 1991
14. van den Born J, van Kraats AA, Bakker MA, et al: Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate. Diabetologia 38:161-172, 1995
15. van Det NF, van den Born J, Tarnsma JT, et al: Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. Kidney Int 49:1079-1089, 1996
16. Templeton DM, Fan MY: Posttranscriptional effects of glucose on proteoglycan expression in mesangial cells. Metabolism 45:1136-1146, 1996
17. Engvall E: Laminin variants: Why, where and when? Kidney Int 43:2-6, 1993
18. Odermatt E, Furthmayr H, Timpl R, et al: Shape, domain structure, and flexibility of laminin, in Kuehn K, Schoene HH, Timpl R (eds): New Trends in Basement Membrane Research. New York, NY, Raven, 1982, pp 79-86
19. Tarsio JF, Reger LA, Furcht LT: Molecular mechanisms in basement membrane complications of diabetes. Alterations in hcparin, laminin, and type IV collagen association. Diabetes 37:532-539, 1988
20. Risteli J, Rohde H, Timpl R: Sensitive radioimmunoassays for 7S collagen and laminin: Application to serum and tissue studies of basement membranes. Anal Biochem 113:372-378, 1981
21. Brocks DG, Strecker H, Neubauer HP, et al: Radioimmunoassay of laminin and its application to cancer patients. Clin Chem 32:787-791, 1986
22. Hasslacher C, Brocks DG: Serum concentration of laminin in type I diabetic patients with and without microangiopathy. Transplant Proc 18:1534, 1986 (abstr)
23. Niemelä O, Risteli L, Sotaniemi EA, et al: Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 15:132-137, 1985
24. Gressner AM, Tittor W: Serum laminin - Its concentration increases with portal hypertension in cirrhotic liver disease. Klin Wochenschr 64:1240-1248, 1986
25. Mogensen CE, Christensen K, Vittinghus E: The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 32:64-78, 1983
26. Horikoshi S, Koide H: Serum laminin Pl fragment concentration in renal diseases. Clin Chim Acta 196:185-191, 1991
27. Nakajima C, Shimojo N, Naka KI, et al: Clinical significance of serum and urinary laminin Pl concentrations in elderly diabetic patients, in Sakamoto N, Alberti KGMM, Hotta N (eds): Current Status of Prevention and Treatment of Diabetic Complications. New York, NY, Elsevier Science, 1990, pp 549-553
28. Yano Y, Sumida Y, Tanaka T, et al: Serum laminin Pl levels in Albustix-negative non-insulin-dependent diabetics, in Sakamoto N, Alberti KGMM, Hotta N (eds): Current Status and Treatment of Diabetic Complications. New York, NY, Elsevier Science, 1990, pp 554-557
29. Tomono S, Kawazu S, Kato N, et al: Clinical implications of serum levels of basement membrane components in diabetic patients with and without albuminuria. J Diabetes Complications 5:193-194, 1991
30. Hayashi Y, Makino H, Ota Z: Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes. Diabet Med 9:366-370, 1992
31. Danne T, Decker J, Schuppan D, et al: Serum levels of laminin Pl and type IV collagen in healthy children and children with insulin-dependent diabetes mellitus, in Gubler MC, Sternberg M (eds): Progress in Basement Membrane Research. Renal and Related Aspects in Health and Disease. Montrouge, France, Libbey Eurotext, 1988, pp 315-322
32. Danne T, Weber B, Spiri MJ, et al: Changes of extracellular matrix metabolism in early diabetic angiopathy, in Weber B, Burger W, Danne T (eds): Structural and Functional Abnormalities in Subclinical Diabetic Angiopathy. Basel, Switzerland, Karger, 1992, pp 11-22
33. Högemann B, Voss B, Altenwerth FJ, et al: Concentrations of 7S collagen and laminin Pl in sera of patients with diabetes mellitus. Klin Wochenschr 64:382-385, 1986
34. Pietschmann P, Schernthaner G, Schnack CH, et al: Serum concentrations of laminin Pl in diabetics with advanced nephropathy. J Clin Pathol 41:929-932, 1988
35. Paulsson M, Saladin K, Engvall E: Structure of laminin variants. The 300-kDa chains of murine and bovine heart laminin are related to the human placenta merosin heavy chain and replace the a chain in some laminin variants. J Biol Chem 266:17545-17551, 1991
36. Kolbe M, Kaufman JL, Friedman J, et al: Changes in steady-state levels of mRNAs coding for type IV collagen, laminin and fibronectin following capillary basement membrane thickening in human adult onset diabetes. Connect Tissue Res 25:77-85, 1990
37. Ledbetter S, Copeland EJ, Noonan D, et al: Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 39:196-203, 1990
38. Poulsom R, Prockop DJ, Boot-Handford RP: Effects of longterm diabetes and galactosaemia upon lens and retinal mRNA levels in the rat. Exp Eye Res 51:27-32, 1990
39. Yurchenco PD, Tsilibary EC, Charonis AS, et al: Models for the self-assembly of basement membrane. J Histochem Cytochem 34:93-102, 1986
40. Charonis AS, Tsilbary EC: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 41:49-51, 1992 (suppl 2)